Our monthly review of FDA-related news items in the world of cardiology includes updates from CardiacSense, MedAlliance, Lupin, Realize Medical and Eli Lilly and Company. 

“Before we examined the data, I thought we would find an ample amount of the symptoms to be specifically associated with long COVID, but that wasn’t the case," one researcher said. 

The finding comes from a new expert consensus statement published by the Society for Cardiovascular Angiography and Interventions. Several industry societies, including the ACC and AHA, have endorsed the document. 

The device was first recalled in 2022, but a new software update has now been released that addresses the issue. The FDA wanted a new recall to be issued to ensure all customers went through with the update.

Peter Libby, MD, a cardiovascular medicine specialist with Brigham and Women’s Hospital, discussed the cases of AFib being seen in long-COVID patients.

Gulati, an award-winning cardiologist and author, first joined Cedars-Sinai in 2022. She is also the president of the American Society for Preventive Cardiology.

Reducing total calorie intake and minimizing large meals, on the other hand, were both linked to improved weight loss. The study followed participants for an average of 6.3 years. 

"If the PHE were suddenly terminated, it would sow confusion and chaos into this critical wind-down," the White House said.

The FDA has cleared U.K.-based Adaptix to market a 3D X-ray system that, according to the company, images hands, feet and elbows “at a fraction of the radiation dose and per-study cost of traditional CT.”